This trial will test 3 doses of a drug to see if it is safe & effective for mild-moderate Alzheimer's patients. It'll last 4-5 months with 4 clinic visits & 1 phone call.
2 Primary · 3 Secondary · Reporting Duration: Screening (up to 42 days) through end of treatment period (12 weeks) for a total of up to 4.2 months
Side Effects for
4 Treatment Groups
1 of 4
1 of 4
1 of 4
1 of 4
320 Total Participants · 4 Treatment Groups
Primary Treatment: 30mg Buntanetap · Has Placebo Group · Phase 2 & 3
Who is running the clinical trial?
Age 55 - 85 · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
|Did not meet criteria||100.0%|
Frequently Asked Questions
Is this study seeking participation from elderly individuals?
"In accordance with the outlined parameters, individuals between 55 and 85 years old are eligible for enrollment in this clinical trial." - Anonymous Online Contributor
In what number of medical facilities is this experimental protocol being implemented?
"Currently, there are 18 sites offering this medical trial. These include Coral Springs, Daytona Beach and DeLand in addition to other locations around the country. It is beneficial for patients to select a nearby location as it reduces travel needs upon enrollment." - Anonymous Online Contributor
Is this research project open for enrollment at present?
"According to the clinicaltrials.gov portal, this research is still recruiting patients. Initially published on April 1st 2023 and recently revised on July 4th 2023, it requires a total of 100 participants from 3 separate sites." - Anonymous Online Contributor
Is it possible for me to become a participant in this trial?
"This research is seeking 320 individuals affected by Alzheimer's Disease between the ages of 55 and 85. To be eligible, one must have a formal diagnosis according to NIA-AA criteria for probable AD; scores on MMSE must fall within 14-24 points range; each participant needs to designate an informed study partner who will accompany them throughout the trial visits and maintain regular contact with the patient (defined as 10 hours per week); certain contraception methods are also mandatory: combined hormonal contraceptives, progestin-only contraceptives, intrauterine devices or systems, bilateral tubal occlusion, vasectomized partners with confirmed absence of sperm in" - Anonymous Online Contributor
How many participants are engaged in this clinical experiment?
"This clinical trial necessitates 320 individuals meeting the designated eligibility requirements to partake. Potential participants can join from The Neurology Institute - Coral Springs in Coral Springs, Florida and Arrow Clinical Trial in Daytona Beach, Georgia among other sites." - Anonymous Online Contributor